Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis

Abstract

Genetic deletion of PKM2 in myeloid cells or limiting its nuclear translocation reduces atherosclerosis by suppressing inflammation and enhancing efferocytosis.